Episode Details
Back to Episodes
Rheumatology Author Roy Fleischmann: Switching Between UPA and ADA
Published 5 years, 5 months ago
Description
Professor Roy Fleischmann, from the University of Texas Southwestern Medical Centre in Dallas, discusses data from the SELECT-COMPARE trial, where patients with RA were switched between upadacitinib and adalimumab in cases of insufficient response.